vs
Andersons, Inc.（ANDE）与Doximity, Inc.（DOCS）财务数据对比。点击上方公司名可切换其他公司
Andersons, Inc.的季度营收约是Doximity, Inc.的1.8倍（$329.5M vs $185.1M），Doximity, Inc.净利率更高（33.3% vs 20.5%，领先12.8%），Doximity, Inc.同比增速更快（9.8% vs -2.4%），过去两年Doximity, Inc.的营收复合增速更高（25.2% vs -1.8%）
安德森公司（The Andersons, Inc.）是1947年成立的美国农业企业，总部位于俄亥俄州莫米。公司起源于1940年代服务粮食行业的安德森货运站，是深耕农业领域的多元化企业，业务覆盖大宗商品贸易、可再生能源以及植物营养板块。
Doximity Inc成立于2010年，是面向医疗专业人士的线上社交服务平台，为平台会员提供精选医疗资讯、远程医疗工具，以及病例协作相关功能，助力医疗从业者高效交流信息、开展诊疗相关工作。
ANDE vs DOCS — 直观对比
营收规模更大
ANDE
是对方的1.8倍
$185.1M
营收增速更快
DOCS
高出12.1%
-2.4%
净利率更高
DOCS
高出12.8%
20.5%
两年增速更快
DOCS
近两年复合增速
-1.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $329.5M | $185.1M |
| 净利润 | $67.4M | $61.6M |
| 毛利率 | 70.3% | 89.9% |
| 营业利润率 | 26.6% | 38.9% |
| 净利率 | 20.5% | 33.3% |
| 营收同比 | -2.4% | 9.8% |
| 净利润同比 | 49.6% | -18.1% |
| 每股收益（稀释后） | — | $0.31 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANDEDOCS
| Q4 25 | $329.5M | $185.1M | ||
| Q3 25 | $295.8M | $168.5M | ||
| Q2 25 | $535.0M | $145.9M | ||
| Q1 25 | $370.8M | $138.3M | ||
| Q4 24 | $337.5M | $168.6M | ||
| Q3 24 | $231.9M | $136.8M | ||
| Q2 24 | $492.5M | $126.7M | ||
| Q1 24 | $341.4M | $118.1M |
净利润ANDEDOCS
| Q4 25 | $67.4M | $61.6M | ||
| Q3 25 | $20.1M | $62.1M | ||
| Q2 25 | $7.9M | $53.3M | ||
| Q1 25 | $284.0K | $62.5M | ||
| Q4 24 | $45.1M | $75.2M | ||
| Q3 24 | $27.4M | $44.2M | ||
| Q2 24 | $36.0M | $41.4M | ||
| Q1 24 | $5.6M | $40.6M |
毛利率ANDEDOCS
| Q4 25 | 70.3% | 89.9% | ||
| Q3 25 | 57.8% | 90.3% | ||
| Q2 25 | 29.6% | 89.2% | ||
| Q1 25 | 41.2% | 89.5% | ||
| Q4 24 | 63.1% | 91.6% | ||
| Q3 24 | 76.4% | 90.0% | ||
| Q2 24 | 35.6% | 89.3% | ||
| Q1 24 | 37.6% | 89.4% |
营业利润率ANDEDOCS
| Q4 25 | 26.6% | 38.9% | ||
| Q3 25 | 8.7% | 37.8% | ||
| Q2 25 | 4.6% | 37.4% | ||
| Q1 25 | 0.9% | 35.2% | ||
| Q4 24 | 19.9% | 47.4% | ||
| Q3 24 | 26.8% | 38.8% | ||
| Q2 24 | 11.6% | 36.4% | ||
| Q1 24 | 4.1% | 35.5% |
净利率ANDEDOCS
| Q4 25 | 20.5% | 33.3% | ||
| Q3 25 | 6.8% | 36.8% | ||
| Q2 25 | 1.5% | 36.5% | ||
| Q1 25 | 0.1% | 45.2% | ||
| Q4 24 | 13.4% | 44.6% | ||
| Q3 24 | 11.8% | 32.3% | ||
| Q2 24 | 7.3% | 32.7% | ||
| Q1 24 | 1.6% | 34.4% |
每股收益（稀释后）ANDEDOCS
| Q4 25 | — | $0.31 | ||
| Q3 25 | $0.59 | $0.31 | ||
| Q2 25 | $0.23 | $0.27 | ||
| Q1 25 | $0.01 | $0.31 | ||
| Q4 24 | $1.31 | $0.37 | ||
| Q3 24 | $0.80 | $0.22 | ||
| Q2 24 | $1.05 | $0.21 | ||
| Q1 24 | $0.16 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | $64.8M |
| 总债务越低越好 | $560.0M | — |
| 股东权益账面价值 | $1.2B | $979.3M |
| 总资产 | $3.7B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资ANDEDOCS
| Q4 25 | $98.3M | $64.8M | ||
| Q3 25 | — | $169.2M | ||
| Q2 25 | — | $137.3M | ||
| Q1 25 | — | $209.6M | ||
| Q4 24 | $561.8M | $165.3M | ||
| Q3 24 | — | $184.2M | ||
| Q2 24 | — | $111.4M | ||
| Q1 24 | — | $96.8M |
总债务ANDEDOCS
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ANDEDOCS
| Q4 25 | $1.2B | $979.3M | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.4B | $1.0B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.0B | ||
| Q3 24 | $1.3B | $961.2M | ||
| Q2 24 | $1.3B | $913.6M | ||
| Q1 24 | $1.3B | $901.4M |
总资产ANDEDOCS
| Q4 25 | $3.7B | $1.2B | ||
| Q3 25 | $3.3B | $1.3B | ||
| Q2 25 | $3.4B | $1.2B | ||
| Q1 25 | $3.8B | $1.3B | ||
| Q4 24 | $4.1B | $1.2B | ||
| Q3 24 | $3.4B | $1.1B | ||
| Q2 24 | $3.3B | $1.1B | ||
| Q1 24 | $3.3B | $1.1B |
负债/权益比ANDEDOCS
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $60.9M |
| 自由现金流经营现金流 - 资本支出 | $-77.1M | — |
| 自由现金流率自由现金流/营收 | -23.4% | — |
| 资本支出强度资本支出/营收 | 21.5% | — |
| 现金转化率经营现金流/净利润 | -0.09× | 0.99× |
| 过去12个月自由现金流最近4个季度 | $-56.1M | — |
8季度趋势，按日历期对齐
经营现金流ANDEDOCS
| Q4 25 | $-6.2M | $60.9M | ||
| Q3 25 | $233.9M | $93.9M | ||
| Q2 25 | $299.3M | $62.1M | ||
| Q1 25 | $-350.0M | $98.5M | ||
| Q4 24 | $268.8M | $65.2M | ||
| Q3 24 | $-2.1M | $68.3M | ||
| Q2 24 | $304.4M | $41.2M | ||
| Q1 24 | $-239.6M | $63.9M |
自由现金流ANDEDOCS
| Q4 25 | $-77.1M | — | ||
| Q3 25 | $167.0M | — | ||
| Q2 25 | $250.5M | — | ||
| Q1 25 | $-396.6M | — | ||
| Q4 24 | $212.9M | — | ||
| Q3 24 | $-40.0M | — | ||
| Q2 24 | $275.8M | — | ||
| Q1 24 | $-266.4M | — |
自由现金流率ANDEDOCS
| Q4 25 | -23.4% | — | ||
| Q3 25 | 56.5% | — | ||
| Q2 25 | 46.8% | — | ||
| Q1 25 | -106.9% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | -17.2% | — | ||
| Q2 24 | 56.0% | — | ||
| Q1 24 | -78.0% | — |
资本支出强度ANDEDOCS
| Q4 25 | 21.5% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 9.1% | — | ||
| Q1 25 | 12.6% | 0.0% | ||
| Q4 24 | 16.6% | 0.0% | ||
| Q3 24 | 16.3% | 0.0% | ||
| Q2 24 | 5.8% | 0.0% | ||
| Q1 24 | 7.8% | 0.0% |
现金转化率ANDEDOCS
| Q4 25 | -0.09× | 0.99× | ||
| Q3 25 | 11.61× | 1.51× | ||
| Q2 25 | 38.10× | 1.16× | ||
| Q1 25 | -1232.46× | 1.58× | ||
| Q4 24 | 5.96× | 0.87× | ||
| Q3 24 | -0.08× | 1.55× | ||
| Q2 24 | 8.46× | 1.00× | ||
| Q1 24 | -42.94× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
